Global Colon Cancer Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 286670
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Colon Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Colon Cancer market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Colon Cancer global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Surgery segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Colon Cancer include Bedford Laboratories, Sanofi Aventis, Bayer, GlaxoSmithKline, and Teva Pharmaceutical Industries, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Colon Cancer market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Surgery

Chemotherapy

Radiation

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

Market segment by players, this report covers

Bedford Laboratories

Sanofi Aventis

Bayer

GlaxoSmithKline

Teva Pharmaceutical Industries

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Colon Cancer product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Colon Cancer, with revenue, gross margin and global market share of Colon Cancer from 2019 to 2022.

Chapter 3, the Colon Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Colon Cancer market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Colon Cancer research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Colon Cancer

1.2 Classification of Colon Cancer by Type

1.2.1 Overview: Global Colon Cancer Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Colon Cancer Revenue Market Share by Type in 2021

1.2.3 Surgery

1.2.4 Chemotherapy

1.2.5 Radiation

1.3 Global Colon Cancer Market by Application

1.3.1 Overview: Global Colon Cancer Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Colon Cancer Market Size & Forecast

1.5 Global Colon Cancer Market Size and Forecast by Region

1.5.1 Global Colon Cancer Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Colon Cancer Market Size by Region, (2017-2022)

1.5.3 North America Colon Cancer Market Size and Prospect (2017-2028)

1.5.4 Europe Colon Cancer Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Colon Cancer Market Size and Prospect (2017-2028)

1.5.6 South America Colon Cancer Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Colon Cancer Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Colon Cancer Market Drivers

1.6.2 Colon Cancer Market Restraints

1.6.3 Colon Cancer Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Bedford Laboratories

2.1.1 Bedford Laboratories Details

2.1.2 Bedford Laboratories Major Business

2.1.3 Bedford Laboratories Colon Cancer Product and Solutions

2.1.4 Bedford Laboratories Colon Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Bedford Laboratories Recent Developments and Future Plans

2.2 Sanofi Aventis

2.2.1 Sanofi Aventis Details

2.2.2 Sanofi Aventis Major Business

2.2.3 Sanofi Aventis Colon Cancer Product and Solutions

2.2.4 Sanofi Aventis Colon Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Sanofi Aventis Recent Developments and Future Plans

2.3 Bayer

2.3.1 Bayer Details

2.3.2 Bayer Major Business

2.3.3 Bayer Colon Cancer Product and Solutions

2.3.4 Bayer Colon Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Bayer Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Colon Cancer Product and Solutions

2.4.4 GlaxoSmithKline Colon Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Teva Pharmaceutical Industries

2.5.1 Teva Pharmaceutical Industries Details

2.5.2 Teva Pharmaceutical Industries Major Business

2.5.3 Teva Pharmaceutical Industries Colon Cancer Product and Solutions

2.5.4 Teva Pharmaceutical Industries Colon Cancer Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Teva Pharmaceutical Industries Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Colon Cancer Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Colon Cancer Players Market Share in 2021

3.2.2 Top 10 Colon Cancer Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Colon Cancer Players Head Office, Products and Services Provided

3.4 Colon Cancer Mergers & Acquisitions

3.5 Colon Cancer New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Colon Cancer Revenue and Market Share by Type (2017-2022)

4.2 Global Colon Cancer Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Colon Cancer Revenue Market Share by Application (2017-2022)

5.2 Global Colon Cancer Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Colon Cancer Revenue by Type (2017-2028)

6.2 North America Colon Cancer Revenue by Application (2017-2028)

6.3 North America Colon Cancer Market Size by Country

6.3.1 North America Colon Cancer Revenue by Country (2017-2028)

6.3.2 United States Colon Cancer Market Size and Forecast (2017-2028)

6.3.3 Canada Colon Cancer Market Size and Forecast (2017-2028)

6.3.4 Mexico Colon Cancer Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Colon Cancer Revenue by Type (2017-2028)

7.2 Europe Colon Cancer Revenue by Application (2017-2028)

7.3 Europe Colon Cancer Market Size by Country

7.3.1 Europe Colon Cancer Revenue by Country (2017-2028)

7.3.2 Germany Colon Cancer Market Size and Forecast (2017-2028)

7.3.3 France Colon Cancer Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Colon Cancer Market Size and Forecast (2017-2028)

7.3.5 Russia Colon Cancer Market Size and Forecast (2017-2028)

7.3.6 Italy Colon Cancer Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Colon Cancer Revenue by Type (2017-2028)

8.2 Asia-Pacific Colon Cancer Revenue by Application (2017-2028)

8.3 Asia-Pacific Colon Cancer Market Size by Region

8.3.1 Asia-Pacific Colon Cancer Revenue by Region (2017-2028)

8.3.2 China Colon Cancer Market Size and Forecast (2017-2028)

8.3.3 Japan Colon Cancer Market Size and Forecast (2017-2028)

8.3.4 South Korea Colon Cancer Market Size and Forecast (2017-2028)

8.3.5 India Colon Cancer Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Colon Cancer Market Size and Forecast (2017-2028)

8.3.7 Australia Colon Cancer Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Colon Cancer Revenue by Type (2017-2028)

9.2 South America Colon Cancer Revenue by Application (2017-2028)

9.3 South America Colon Cancer Market Size by Country

9.3.1 South America Colon Cancer Revenue by Country (2017-2028)

9.3.2 Brazil Colon Cancer Market Size and Forecast (2017-2028)

9.3.3 Argentina Colon Cancer Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Colon Cancer Revenue by Type (2017-2028)

10.2 Middle East & Africa Colon Cancer Revenue by Application (2017-2028)

10.3 Middle East & Africa Colon Cancer Market Size by Country

10.3.1 Middle East & Africa Colon Cancer Revenue by Country (2017-2028)

10.3.2 Turkey Colon Cancer Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Colon Cancer Market Size and Forecast (2017-2028)

10.3.4 UAE Colon Cancer Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Colon Cancer Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Colon Cancer Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Colon Cancer Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Colon Cancer Revenue (USD Million) by Region (2017-2022)

Table 5. Global Colon Cancer Revenue Market Share by Region (2023-2028)

Table 6. Bedford Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Bedford Laboratories Major Business

Table 8. Bedford Laboratories Colon Cancer Product and Solutions

Table 9. Bedford Laboratories Colon Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Sanofi Aventis Corporate Information, Head Office, and Major Competitors

Table 11. Sanofi Aventis Major Business

Table 12. Sanofi Aventis Colon Cancer Product and Solutions

Table 13. Sanofi Aventis Colon Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Bayer Corporate Information, Head Office, and Major Competitors

Table 15. Bayer Major Business

Table 16. Bayer Colon Cancer Product and Solutions

Table 17. Bayer Colon Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline Major Business

Table 20. GlaxoSmithKline Colon Cancer Product and Solutions

Table 21. GlaxoSmithKline Colon Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors

Table 23. Teva Pharmaceutical Industries Major Business

Table 24. Teva Pharmaceutical Industries Colon Cancer Product and Solutions

Table 25. Teva Pharmaceutical Industries Colon Cancer Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Global Colon Cancer Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 27. Global Colon Cancer Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 28. Breakdown of Colon Cancer by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Colon Cancer Players Head Office, Products and Services Provided

Table 30. Colon Cancer Mergers & Acquisitions in the Past Five Years

Table 31. Colon Cancer New Entrants and Expansion Plans

Table 32. Global Colon Cancer Revenue (USD Million) by Type (2017-2022)

Table 33. Global Colon Cancer Revenue Share by Type (2017-2022)

Table 34. Global Colon Cancer Revenue Forecast by Type (2023-2028)

Table 35. Global Colon Cancer Revenue by Application (2017-2022)

Table 36. Global Colon Cancer Revenue Forecast by Application (2023-2028)

Table 37. North America Colon Cancer Revenue by Type (2017-2022) & (USD Million)

Table 38. North America Colon Cancer Revenue by Type (2023-2028) & (USD Million)

Table 39. North America Colon Cancer Revenue by Application (2017-2022) & (USD Million)

Table 40. North America Colon Cancer Revenue by Application (2023-2028) & (USD Million)

Table 41. North America Colon Cancer Revenue by Country (2017-2022) & (USD Million)

Table 42. North America Colon Cancer Revenue by Country (2023-2028) & (USD Million)

Table 43. Europe Colon Cancer Revenue by Type (2017-2022) & (USD Million)

Table 44. Europe Colon Cancer Revenue by Type (2023-2028) & (USD Million)

Table 45. Europe Colon Cancer Revenue by Application (2017-2022) & (USD Million)

Table 46. Europe Colon Cancer Revenue by Application (2023-2028) & (USD Million)

Table 47. Europe Colon Cancer Revenue by Country (2017-2022) & (USD Million)

Table 48. Europe Colon Cancer Revenue by Country (2023-2028) & (USD Million)

Table 49. Asia-Pacific Colon Cancer Revenue by Type (2017-2022) & (USD Million)

Table 50. Asia-Pacific Colon Cancer Revenue by Type (2023-2028) & (USD Million)

Table 51. Asia-Pacific Colon Cancer Revenue by Application (2017-2022) & (USD Million)

Table 52. Asia-Pacific Colon Cancer Revenue by Application (2023-2028) & (USD Million)

Table 53. Asia-Pacific Colon Cancer Revenue by Region (2017-2022) & (USD Million)

Table 54. Asia-Pacific Colon Cancer Revenue by Region (2023-2028) & (USD Million)

Table 55. South America Colon Cancer Revenue by Type (2017-2022) & (USD Million)

Table 56. South America Colon Cancer Revenue by Type (2023-2028) & (USD Million)

Table 57. South America Colon Cancer Revenue by Application (2017-2022) & (USD Million)

Table 58. South America Colon Cancer Revenue by Application (2023-2028) & (USD Million)

Table 59. South America Colon Cancer Revenue by Country (2017-2022) & (USD Million)

Table 60. South America Colon Cancer Revenue by Country (2023-2028) & (USD Million)

Table 61. Middle East & Africa Colon Cancer Revenue by Type (2017-2022) & (USD Million)

Table 62. Middle East & Africa Colon Cancer Revenue by Type (2023-2028) & (USD Million)

Table 63. Middle East & Africa Colon Cancer Revenue by Application (2017-2022) & (USD Million)

Table 64. Middle East & Africa Colon Cancer Revenue by Application (2023-2028) & (USD Million)

Table 65. Middle East & Africa Colon Cancer Revenue by Country (2017-2022) & (USD Million)

Table 66. Middle East & Africa Colon Cancer Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Colon Cancer Picture

Figure 2. Global Colon Cancer Revenue Market Share by Type in 2021

Figure 3. Surgery

Figure 4. Chemotherapy

Figure 5. Radiation

Figure 6. Colon Cancer Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Ambulatory Surgical Centers Picture

Figure 9. Others Picture

Figure 10. Global Colon Cancer Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Colon Cancer Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Colon Cancer Revenue Market Share by Region (2017-2028)

Figure 13. Global Colon Cancer Revenue Market Share by Region in 2021

Figure 14. North America Colon Cancer Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Colon Cancer Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Colon Cancer Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Colon Cancer Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Colon Cancer Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Colon Cancer Market Drivers

Figure 20. Colon Cancer Market Restraints

Figure 21. Colon Cancer Market Trends

Figure 22. Bedford Laboratories Recent Developments and Future Plans

Figure 23. Sanofi Aventis Recent Developments and Future Plans

Figure 24. Bayer Recent Developments and Future Plans

Figure 25. GlaxoSmithKline Recent Developments and Future Plans

Figure 26. Teva Pharmaceutical Industries Recent Developments and Future Plans

Figure 27. Global Colon Cancer Revenue Share by Players in 2021

Figure 28. Colon Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 29. Global Top 3 Players Colon Cancer Revenue Market Share in 2021

Figure 30. Global Top 10 Players Colon Cancer Revenue Market Share in 2021

Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 32. Global Colon Cancer Revenue Share by Type in 2021

Figure 33. Global Colon Cancer Market Share Forecast by Type (2023-2028)

Figure 34. Global Colon Cancer Revenue Share by Application in 2021

Figure 35. Global Colon Cancer Market Share Forecast by Application (2023-2028)

Figure 36. North America Colon Cancer Sales Market Share by Type (2017-2028)

Figure 37. North America Colon Cancer Sales Market Share by Application (2017-2028)

Figure 38. North America Colon Cancer Revenue Market Share by Country (2017-2028)

Figure 39. United States Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe Colon Cancer Sales Market Share by Type (2017-2028)

Figure 43. Europe Colon Cancer Sales Market Share by Application (2017-2028)

Figure 44. Europe Colon Cancer Revenue Market Share by Country (2017-2028)

Figure 45. Germany Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. France Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. United Kingdom Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Russia Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Italy Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Asia-Pacific Colon Cancer Sales Market Share by Type (2017-2028)

Figure 51. Asia-Pacific Colon Cancer Sales Market Share by Application (2017-2028)

Figure 52. Asia-Pacific Colon Cancer Revenue Market Share by Region (2017-2028)

Figure 53. China Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Japan Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. South Korea Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. India Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Southeast Asia Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Australia Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South America Colon Cancer Sales Market Share by Type (2017-2028)

Figure 60. South America Colon Cancer Sales Market Share by Application (2017-2028)

Figure 61. South America Colon Cancer Revenue Market Share by Country (2017-2028)

Figure 62. Brazil Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Argentina Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Middle East and Africa Colon Cancer Sales Market Share by Type (2017-2028)

Figure 65. Middle East and Africa Colon Cancer Sales Market Share by Application (2017-2028)

Figure 66. Middle East and Africa Colon Cancer Revenue Market Share by Country (2017-2028)

Figure 67. Turkey Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Saudi Arabia Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. UAE Colon Cancer Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Methodology

Figure 71. Research Process and Data Source